Skip to content

Earnings yield at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
1.8%+0.4pp
Theravance Biopharma logo
Theravance BiopharmaTBPH
13.7%+9.2pp
Savara logo
SavaraSVRA
-11.6%-3.6pp
LQD
Liquidia CorporationLQDA
-6.2%-2.3pp
United Therapeutics logo
United TherapeuticsUTHR
5%-3.8pp
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
4.2%-0.1pp

Other financials

Income statement

See full
Revenue$20.6M-8.7%
Gross profit$16.0M-1.8%
Operating income-$13.0M+11.0%
Net income-$13.7M+5.5%
EPS (diluted)-$0.33+8.3%

Balance sheet

See full
Cash & equivalents$61.0M-2.4%
Total debt$56.3M-1.2%
Total equity$45.8M-41.1%
Total assets$120.0M-20.4%

Cash flow

See full
Operating cash flow-$10.1M+23.6%
CapEx$9.0K-97.0%
Free cash flow-$10.1M+25.3%

Valuation

See full
Market cap$54.91M-47.3%
Enterprise value$50.17M-43.5%
P/S0.6×-0.5×

Profitability

See full
Gross margin75.5%+2.0pp
Operating margin-58.8%-5.8pp
Net margin-60.1%-4.4pp
FCF margin-33.2%-4.4pp

Returns & leverage

See full
Return on equity-86.2%+62.6pp
Debt / equity1.2×+0.5×
Current ratio4.9×-0.1×

Where this comes from

Calculated from Pulmonx Corporation’s reported figures.

Based on trailing twelve months.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulmonx Corporation's earnings yield?
Pulmonx Corporation (LUNG) reported earnings yield of -97.7% in Q1 2026.
How has Pulmonx Corporation's earnings yield changed year-over-year?
Pulmonx Corporation's earnings yield decreased by 358.1% year-over-year, from -21.3% to -97.7%.
What is the long-term trend for Pulmonx Corporation's earnings yield?
Over 5 years (2020 to 2025), Pulmonx Corporation's earnings yield has grown at a 114.0% compound annual growth rate (CAGR), from -1.3% to -59.2%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.